Average weight dropped from 98.1 kg (216.3 lb) to 86.7 kg (191.1 lb) in the tirzepatide arm as compared with 96 kg (211.6 lb) to 93.5 kg (206.1 lb) in the dulaglutide dose-escalation arm.

For adults struggling with weight, a weekly injection of tirzepatide offers real hope. Recent findings presented at the ...

In the 176-week study run over three years – which underpinned tirzepatide's approval for obesity last year – once-weekly injections of tirzepatide at three dose levels – 5, 10, and 15 mg ...

Jaime Almandoz, MD, MBA, of UT Southwestern Medical Center, speaks on results of a study that investigated tirzepatide uptake ...

See which services passed our medical vetting process. Share on Pinterest Mounjaro (tirzepatide), the injectable medication that’s approved for diabetes by the Food and Drug Administration (FDA ...

Lilly is suing Mochi Health, Henry Meds, Willow Health and Fella Health, claiming they are illegally selling compounded versions of tirzepatide. Lilly's suits argue that the knock-off tirzepatide ...

Tirzepatide is approved for 3 indications in the US: type 2 diabetes, chronic weight management, and obstructive sleep apnea.

Consistent with known effects of GLP-1/GIP therapy, over 50% of lost weight was regained within two weeks of stopping treatment in both the tirzepatide and co-administration arms of the study.

Participants given tirzepatide lowered their HbA1c by a mean 0.77% more than those given a higher dulaglutide dose. More tirzepatide participants hit a weight loss threshold known for disease ...

The study included a co-administered melanocortin 4 receptor – MC4R – agonist bremelanotide plus glucagon like peptide-1/gastric inhibitory polypeptide, or GLP-1/GIP, tirzepatide arm ...

Boston, MA—Boston Plastic Surgery is pleased to announce the introduction of GLP-1 weight loss injections with semaglutide and tirzepatide, to its suite of wellness services. With this addition ...